Hyderabad-based vaccine maker Biological E (BE) today said it would be investing up to Rs 300 crore in a new plant coming up in the special economic zone (SEZ) here.
This investment is in line with and part of Rs 1,000 crore outlay already earmarked in Hyderabad Genome Valley across BE's vaccines and pharma businesses, according to the company's managing director Mahima Datla.
The construction of the new vaccine manufacturing facility, for which the foundation stone was laid on Monday, on about 29 acres of land would be completed by April 2018 and the commercial production is expected to begin